NCT06224673 2026-02-13ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerUniversity of California, San FranciscoPhase 2 Not yet recruiting36 enrolled
NCT06492759 2025-12-16High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast CancerEmory UniversityPhase 2 Not yet recruiting29 enrolled